A Single-Arm, Open-Label Study of the Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Red Blood Cell Transfusion-Dependent Myelodysplastic Syndromes.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2011
At a glance
- Drugs Ciclosporin; Lenalidomide
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 08 Mar 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 08 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Mar 2011 Last checked against ClinicalTrials.gov record.